DK40191A - Behandling af knoglelidelser - Google Patents

Behandling af knoglelidelser Download PDF

Info

Publication number
DK40191A
DK40191A DK040191A DK40191A DK40191A DK 40191 A DK40191 A DK 40191A DK 040191 A DK040191 A DK 040191A DK 40191 A DK40191 A DK 40191A DK 40191 A DK40191 A DK 40191A
Authority
DK
Denmark
Prior art keywords
amylin
bone
treatment
disorders
variants
Prior art date
Application number
DK040191A
Other languages
English (en)
Other versions
DK40191D0 (da
Inventor
Iain Macintyre
Original Assignee
Amylin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Corp filed Critical Amylin Corp
Publication of DK40191D0 publication Critical patent/DK40191D0/da
Publication of DK40191A publication Critical patent/DK40191A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DK040191A 1989-07-08 1991-03-07 Behandling af knoglelidelser DK40191A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898915712A GB8915712D0 (en) 1989-07-08 1989-07-08 Medical treatment
PCT/US1990/003841 WO1991000710A1 (en) 1989-07-08 1990-07-07 Treatment of bone disorders

Publications (2)

Publication Number Publication Date
DK40191D0 DK40191D0 (da) 1991-03-07
DK40191A true DK40191A (da) 1991-03-07

Family

ID=10659773

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90307471.4T DK0408284T3 (da) 1989-07-08 1990-07-09 Amylin til behandling af knoglelidelser
DK040191A DK40191A (da) 1989-07-08 1991-03-07 Behandling af knoglelidelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK90307471.4T DK0408284T3 (da) 1989-07-08 1990-07-09 Amylin til behandling af knoglelidelser

Country Status (12)

Country Link
EP (1) EP0408284B1 (da)
JP (1) JPH04500691A (da)
AT (1) ATE137975T1 (da)
CA (1) CA2020752C (da)
DE (1) DE69026986T2 (da)
DK (2) DK0408284T3 (da)
ES (1) ES2088971T3 (da)
GB (1) GB8915712D0 (da)
GR (1) GR3020680T3 (da)
IE (1) IE62625B1 (da)
SG (1) SG46382A1 (da)
WO (1) WO1991000710A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG49239A1 (en) * 1991-05-24 1998-05-18 Amylin Pharmaceuticals Inc Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
EP0586592B1 (en) * 1991-05-24 2000-11-29 Amylin Pharmaceuticals, Inc. Insulin and amylin containing composition for the treatment of insulin deficient mammals
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
WO1993019774A1 (en) * 1992-04-03 1993-10-14 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ATE287390T1 (de) 1994-10-21 2005-02-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
ATE430123T1 (de) 1996-05-01 2009-05-15 Nps Pharma Inc Inorganische am ionen-rezeptor aktive verbindungen
US6869926B1 (en) 1997-09-26 2005-03-22 Auckland Uniservices Limited Therapeutic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GB8407907D0 (en) * 1984-03-27 1984-05-02 Sandoz Ltd Organic compounds
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
JPS62129297A (ja) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd カルシトニン遺伝子関連ペプチド誘導体
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
HU203198B (en) * 1987-10-26 1991-06-28 Sandoz Ag Process for producing pharmaceutical compositions having immunity-inhibiting, monokin-, particularly interleukin-1-inhibiting effect
JP2944117B2 (ja) * 1988-07-22 1999-08-30 エチル・コーポレーション 骨の処置におけるケイ素化合物

Also Published As

Publication number Publication date
GB8915712D0 (en) 1989-08-31
GR3020680T3 (en) 1996-10-31
SG46382A1 (en) 1998-02-20
IE902494A1 (en) 1991-02-13
CA2020752A1 (en) 1992-01-10
EP0408284B1 (en) 1996-05-15
ES2088971T3 (es) 1996-10-01
DK0408284T3 (da) 1996-06-03
DK40191D0 (da) 1991-03-07
CA2020752C (en) 1996-12-24
IE62625B1 (en) 1995-02-22
EP0408284A3 (en) 1992-01-08
DE69026986D1 (de) 1996-06-20
WO1991000710A1 (en) 1991-01-24
DE69026986T2 (de) 1996-10-02
JPH04500691A (ja) 1992-02-06
ATE137975T1 (de) 1996-06-15
EP0408284A2 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
DK40191D0 (da) Behandling af knoglelidelser
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
ATE111331T1 (de) Schiene zur behandlung der fraktur von colles.
FR2621245B1 (fr) Table d'operation orthopedique pour membres et notamment pour membres inferieurs
IS2132B (is) Notkun á estrogeni til framleiðslu á lyfi til meðhöndlunar vegna tíðahvarfa
AU1808488A (en) Compounds for the treatment of alzheimer's disease
GB2193102B (en) Fracture brace
IL88080A0 (en) Substituted tetralins,chromans and related compounds in the treatment of asthma,arthritis and related diseases
GB8621816D0 (en) Therapeutic composition
FR2651435B1 (da)
AU2824289A (en) Thienotricyclene for the treatment of bronchial diseases
FR2677874B1 (fr) Broche pour la chirurgie de la main selon la methode de kapandji.
EP0486584A4 (en) Dopaminergic neurotrophic factor for treatment of parkinson's disease
EP0295827A3 (en) Use of 24,25-dihydroxy-cholecalciferol in mending bone fractures
FR2649310B1 (fr) Broche intra-focale a effet de reduction pour l'osteosynthese des fractures
NZ221473A (en) Octapeptide somatostatin analogue "octreotide" in nasal compositions
GB8908549D0 (en) Liquid leather treatment composition
Maki et al. Follow-Up Study on Tendon Transfer for Extension Disturbance of Wrist, Thumb, and Finger
GR860897B (en) Woman's heel
IT1238692B (it) Composizioni farmaceutiche a base di calcitonina per la somministrazione sublinguale
IT1238074B (it) Composti per il trattamento della malattia di paget,dell'ipercalcemia e dell'osteoporosi ottenuti per complessazione di una delle calcitonine con una ciclodestrina, loro preparazione e relative composizioni farmaceutiche
IT8619540A0 (it) Acciaio resistente all'usura eprocedimento per il suo ottenimento.
CS768788A1 (en) Dispersing agent for leathers' surface treatment properties improvement

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment